Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Syndeio is a pioneering biotech advancing synapse-targeted therapies for neuropsychiatric and cognitive disorders. Leveraging deep expertise in synapse biology and our proprietary pharmacology platform, we develop novel drug candidates with differentiated mechanisms of action. Our breakthrough event-driven pharmacology approach enables single doses to induce lasting neural changes, strengthening synaptic connections. This inno...
Syndeio is a pioneering biotech advancing synapse-targeted therapies for neuropsychiatric and cognitive disorders. Leveraging deep expertise in synapse biology and our proprietary pharmacology platform, we develop novel drug candidates with differentiated mechanisms of action. Our breakthrough event-driven pharmacology approach enables single doses to induce lasting neural changes, strengthening synaptic connections. This innovative paradigm unlocks potential for rapid-acting, safe, and durable treatments that could transform care for brain disorders

List your booth number for exhibitions, ask us